| Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ... The Lancet Respiratory Medicine 9 (5), 522-532, 2021 | 256 | 2021 |
| Interleukin-5 in the pathophysiology of severe asthma C Pelaia, G Paoletti, F Puggioni, F Racca, G Pelaia, GW Canonica, ... Frontiers in physiology 10, 1514, 2019 | 215 | 2019 |
| Inhaled corticosteroids safety and adverse effects in patients with asthma E Heffler, LNG Madeira, M Ferrando, F Puggioni, F Racca, L Malvezzi, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (3), 776-781, 2018 | 169 | 2018 |
| The severe asthma network in Italy: findings and perspectives E Heffler, F Blasi, M Latorre, F Menzella, P Paggiaro, G Pelaia, G Senna, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (5), 1462-1468, 2019 | 163 | 2019 |
| Monophosphoryl lipid A (MPL®)* promotes allergen‐induced immune deviation in favour of Th1 responses F Puggioni, SR Durham, JN Francis Allergy 60 (5), 678-684, 2005 | 143 | 2005 |
| Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19 J Bousquet, JM Anto, W Czarlewski, T Haahtela, SC Fonseca, G Iaccarino, ... Allergy 76 (3), 735-750, 2021 | 127 | 2021 |
| Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry GW Canonica, GL Colombo, GM Bruno, S Di Matteo, C Martinotti, F Blasi, ... World Allergy Organization Journal 12 (1), 100007, 2019 | 112 | 2019 |
| Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients E Heffler, C Crimi, S Mancuso, R Campisi, F Puggioni, L Brussino, N Crimi Respiratory medicine 142, 48-52, 2018 | 108 | 2018 |
| Extended IgE profile based on an allergen macroarray: a novel tool for precision medicine in allergy diagnosis E Heffler, F Puggioni, S Peveri, M Montagni, GW Canonica, G Melioli World Allergy Organization Journal 11, 7, 2018 | 105 | 2018 |
| ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020) J Bousquet, M Jutel, CA Akdis, L Klimek, O Pfaar, KC Nadeau, T Eiwegger, ... Allergy 76 (3), 689-697, 2021 | 97 | 2021 |
| Defining a severe asthma super-responder: findings from a Delphi process JW Upham, C Le Lievre, DJ Jackson, M Masoli, ME Wechsler, DB Price, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (11), 3997-4004, 2021 | 96 | 2021 |
| Anti-interleukin 5 (IL-5) and IL-5Ra biological drugs: efficacy, safety, and future perspectives in severe eosinophilic asthma D Bagnasco, M Ferrando, G Varricchi, F Puggioni, G Passalacqua, ... Frontiers in medicine 4, 135, 2017 | 89 | 2017 |
| Asthma: personalized and precision medicine GW Canonica, M Ferrando, I Baiardini, F Puggioni, F Racca, ... Current opinion in allergy and clinical immunology 18 (1), 51-58, 2018 | 81 | 2018 |
| Nrf2‐interacting nutrients and COVID‐19: time for research to develop adaptation strategies J Bousquet, JP Cristol, W Czarlewski, JM Anto, A Martineau, T Haahtela, ... Clinical and translational allergy 10 (1), 58, 2020 | 79 | 2020 |
| ARIA digital anamorphosis: digital transformation of health and care in airway diseases from research to practice J Bousquet, JM Anto, C Bachert, T Haahtela, T Zuberbier, W Czarlewski, ... Allergy 76 (1), 168-190, 2021 | 70 | 2021 |
| Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus J Hagemann, GL Onorato, M Jutel, CA Akdis, I Agache, T Zuberbier, ... Allergy 76 (8), 2354-2366, 2021 | 53 | 2021 |
| Asthma from immune pathogenesis to precision medicine K Khalaf, G Paoletti, F Puggioni, F Racca, F De Luca, V Giorgis, ... Seminars in Immunology 46, 101294, 2019 | 49 | 2019 |
| Patient knowledge, perceptions, expectations and satisfaction on allergen-specific immunotherapy: a survey I Baiardini, F Puggioni, S Menoni, JD Boot, Z Diamant, F Braido, ... Respiratory medicine 107 (3), 361-367, 2013 | 42 | 2013 |
| Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) GW Canonica, F Blasi, P Paggiaro, G Senna, G Passalacqua, ... World Allergy Organization Journal 13 (10), 100464, 2020 | 41 | 2020 |
| Immunostimulants in respiratory diseases: focus on Pidotimod F Puggioni, M Alves-Correia, MF Mohamed, N Stomeo, R Mager, ... Multidisciplinary Respiratory Medicine 14, 1-10, 2019 | 39 | 2019 |
